Combined oral contraceptives with shortened hormone-free interval. Proven advantages of the therapy regime ; Комбинированные оральные контрацептивы с укороченным безгормональным интервалом. Доказанные преимущества режима

Authors: G. B. Dikke, Г. Б. Дикке

Source: Meditsinskiy sovet = Medical Council; № 13 (2019); 56-62 ; Медицинский Совет; № 13 (2019); 56-62 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2019-13

Subject Terms: диеногест, hormone-free interval, 26/2 mode, estradiol valerate, dienogest, безгормональный интервал, режим 26/2, эстрадиола валерат

File Description: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/3900/3493; Hooper D.J. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey. Clin Drug Investig. 2010;30(11):74963. doi:10.2165/11538900-000000000-00000.; Дикке Г.Б., Ерофеева Л.В. Современные особенности национальной контрацепции: информированность, применение и эффективность. Вопросы гинекологии, акушерства и перинатологии. 2014;1(5):63–71. Режим доступа: http://www.phdynasty.ru/katalog/zhurnaly/voprosy-ginekologii-akusherstva-iperinatologii/2014/tom-13-nomer-5/25159.; Жук С.И., Захурдаева Л.Д. Особенности современного консультирования по вопросам контрацепции. Медицинские аспекты здоровья женщины. 2011;(4). Электронный ресурс. Режим доступа: http://fetalmedic.com/kontracepciya/osobennosti-sovremennogo-konsultirovaniya-povoprosamkontracepcii.html.; Premenstrual syndrome: Overview. In: Informed Health Online. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2017. Available at: https://www.ncbi.nlm.nih.gov/books/NBK279265/; Cooper D.B., Adigun R. Oral Contraceptive Pills. Treasure Island (FL): StatPearls Publishing; 2018 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430882/; Nappi R.E., Nappi G. Neuroendocrine aspects of migraine in women. Gynecol Endocrinol. 2012 Mar;28(Suppl 1):37-41. doi:10.3109/09513590.2012.651931.; Allais G., Gabellari I.C., Airola G., Borgogno P, Schiapparelli P, Benedetto C. Headache induced by the use of combined oral contraceptives. Neurol Sci. 2009; 30(Suppl )1:15-17. doi:10.1007/s10072-009-0051-9.; Sulak P.J., Cressman B.E., Waldrop E., Holleman S., Kuehl T.J. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol. 1997;89(2): 179–183. doi:10.1016/S0029-7844(96)00488-7.; Sulak P.J., Scow R.D., Preece C., Riggs M.W., Kuehl T.J. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95(2):261– 266. doi:10.1016/s0029-7844(99)00524-4.; LaGuardia K.D., Fisher A.C., Bainbridge J.D., LoCoco J.M., Friedman A.J. Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril. 2005;83(6):1875–1877. doi:10.1016/j.fertnstert.2004.12.048.; Loder E.W., Buse D.C., Golub J.R. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache. 2005;45(3):224– 231. doi:10.1111/j.1526-4610.2005.05049.x.; Chai N.C., Peterlin B.L., Calhoun A.H. Migraine and estrogen. Curr Opin Neurol. 2014;27(3):315-24. doi:10.1097/WCO.0000000000000091.; Sacco S., Ricci S., Degan D., Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3): 177-89. doi:10.1007/s10194-0120424-y.; De Leo V., Scolaro V., Musacchio M.C., Di Sabatino A., Morgante G., Cianci A. Combined oral contraceptives in women with menstrual migraine without aura. Fertil Steril. 2011;96(4):917-920. doi:10.1016/j.fertnstert.2011.07.1089.; Bardin L. The complex role of serotonin and 5-HT receptors in chronic pain. Behav Pharmacol. 2011;22(5-6):390-404. doi:10.1097/FBP.0b013e328349aae4.; Allais G., Chiarle G., Sinigaglia S., Airola G., Schiapparelli P., Benedetto C. Estrogen, migraine, and vascular risk. Neurol Sci. 2018;39(Suppl 1):11-20. doi:10.1007/s10072-018-3333-2.; Carhart-Harris R.L., Nutt D.J. Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 2017;31(9):1091-120. doi:10.1177/0269881117725915.; Modena M.G. Estrogens and the Heart: Do they Help or Hurt? How Estrogen impacts the Cardiovascular System. SOJ Gynecol Obstet Womens Health. 2016;2(1):8. doi:10.15226/2381-2915/2/1/00108.; Karli N., Baykan B., Ertas M., Zarifoğlu M., Siva A., Saip S., Ozkaya G. Turkish Headache Prevalence Study Group, Onal AE. Turkish headache prevalence study group. impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain. 2012;13(7):557565. doi:10.1007/s10194-012-0475-0.; Shaik M.M., Gan S.H. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. Biomed Res Int. 2015:469529. doi:10.1155/2015/469529.; Graziottin A. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval. Eur J Contracept Reprod Health Care. 2016;21(2):93-105. doi:10.3109/13625187.2015.1077380.; Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 3d edition. Cephalalgia. 2018;38(1):1– 211. doi:10.1177/0333102417738202.; Bitzer J. Hormone withdrawal-associated symptoms: overlooked and under-explored. Gynecological Endocrinology. 2013;29(6):530-5. doi:10.3109/09513590.2012.760194.; Hauck B.A., Brown V. A primer on the hormonefree interval for combined oral contraceptives. Curr Med Res Opin. 2015;31(10):1941-8. doi:10.1185/03007995.2015.1082989.; Grandi G., Napolitano A., Xholli A., Tirelli A., Di Carlo C., Cagnacci A. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea. Gynecol Endocrinol. 2015;31(10):774-778. doi:10.3109/09513590.2015.1063118.; Bitzer J., Banal-Silao M.J., Ahrendt H.J., Restrepo J., Hardtke M., Wissinger-Graefenhahn U., Trummer D. Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/ drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen). Int J Womens Health. 2015;7:501-509. doi:10.2147/IJWH.S77942.; Jensen J.T., Parke S., Mellinger U., Serrani M., Mabey R.J. Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/ dienogest versus ethinylestradiol/norgestimate. Eur J Contracep Reprod Health Care. 2013;18(4): 274-83. doi:10.3109/13625187.2013.785516.; Macias G., Merki-Feld S., Parke S., Mellinger U., Serrani M. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, doubleblind, active-controlled HARMONY II study. J Obstet Gynaecol. 2013;33(6):591-6. doi:10.3109/01443615.2013.800851.; Edelman A., Micks E., Gallo M.F., Jensen J.T., Grimes D.A. Continuous or extended cycle vs cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;(7): CD004695. doi:10.1002/14651858.CD004695.pub3.; MacGregor E.A., Guillebaud J. The 7-day contraceptive hormone-free interval should be consigned to history. BMJ Sex Reprod Health. 2018;pii:bmjsrh-2017200036. doi:10.1136/bmjsrh-2017-200036.; Read C.M. New regimens with combined oral contraceptive pills – moving away from traditional 21/7 cycles. Eur J Contracept Reprod Health Care. 2010;15(Suppl 2):32-41. doi:10.3109/13625187.2010.529969.; London A., Jensen J.T. Rationale for eliminating the hormone-free interval in modern oral contraceptives. J Obstet Gynaecology. 2016;134(1):812. doi:10.1016/j.ijgo.2015.10.028.; Barnett C., Hagemann C., Dinger J., Do Minh T., Heinemann K. Fertility and combined oral contraceptives – unintended pregnancies and planned pregnancies following oral contraceptive use – results from the INAS-SCORE study. Eur J Contracept Reprod Health Care. 2017;22(1):17-23. doi:10.1080/13625187.2016.1241991.; Briggs P., Serrani M., Vogtlander K., Parke S. Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogenonly pill after switching from an ethinylestradiolcontaining pill in a real-life setting: results of the CONTENT study. Int. J. Womens Health. 2016;(8):477–487. doi:10.2147/IJWH.S107586.

Availability: https://www.med-sovet.pro/jour/article/view/3900
https://doi.org/10.21518/2079-701X-2019-13-56-62

Uterine bleedings and quality of woman's life

Source: Reproductive Endocrinology; № 47 (2019); 8-12
Репродуктивная эндокринология; № 47 (2019); 8-12
Репродуктивна ендокринологія; № 47 (2019); 8-12

Subject Terms: 03 medical and health sciences, резолюція Експертної ради, аномальні маткові кровотечі, менструальні симптоми, комбіновані оральні контрацептиви, безгормональний інтервал, 0302 clinical medicine, resolution of Advisory Board, abnormal uterine bleeding, menstrual symptoms, combined oral contraceptives, hormonal free interval, резолюция Экспертного совета, аномальные маточные кровотечения, менструальные симптомы, комбинированные оральные контрацептивы, безгормональный интервал, 3. Good health

File Description: application/pdf

Access URL: http://reproduct-endo.com/article/view/170081